Therefore, immune dysfunction, abnormal activation of NF-kB, epithelial-to-mesenchymal transition (EMT), altered adhesion signaling pathways, and extracellular matrix degradation/altered signaling might be the key underlying mechanisms in both COPD and lung cancer[12]. This evidence concerns the gene NFKB1 and lung cancer.